|
Droperidol Injection
» Droperidol Injection is a sterile solution of Droperidol in Water for Injection, prepared with the aid of Lactic Acid. It contains not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C22H22FN3O2, as the lactate.
Packaging and storage
Preserve in single-dose or multiple-dose containers, preferably of Type I glass, protected from light.
Identification
A:
Dissolve about 25 mg of USP Droperidol RS in 10 mL of water containing 0.3 mL of 50% acetic acid in a separator to obtain a solution containing about 2.5 mg per mL. Transfer a volume of Injection, equivalent to about 25 mg of droperidol, to a second separator. Separately add 2 mL of ammonia TS to each separator, and mix. Extract each solution with two 10-mL portions of chloroform, collecting the chloroform extracts from the solutions in separate 50-mL beakers. Apply separately 20 µL of the test solution and the Standard solution to a thin-layer chromatographic plate (see Chromatography
B:
The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation as obtained in the Assay.
Bacterial endotoxins
pH
Chromatographic purity
Mobile phase, System suitability preparation, Standard stock preparation, Standard preparation, and Chromatographic system
Proceed as directed in the Assay.
Test preparation
Use the Assay preparation.
Procedure
Inject a volume (about 100 µL) of the Test preparation into the chromatograph, record the chromatogram of twice the retention time of droperidol, and measure the peak responses. Calculate the percentage of each impurity in the portion of Droperidol taken by the formula:
100(ri / rs)
in which ri is the peak response for each impurity, and rs is the sum of the responses of all the peaks: the sum of all impurities is not more than 2.0%.
Other requirements
It meets the requirements under Injections
Assay
Borate buffer
Dissolve 31 g of boric acid in about 800 mL of water. Slowly add sodium hydroxide solution (1 in 5) in small quantities until all of the boric acid is dissolved and the pH is constant at 7.0. Quantitatively transfer the solution to a glass-stoppered, 1000-mL volumetric flask, dilute with water to volume, and mix.
Mobile phase
Prepare a filtered and degassed mixture of methanol, water, and Borate buffer (700:280:20). Make adjustments if necessary (see System Suitability under Chromatography
Standard preparation
Transfer 5.0 mL of Standard stock preparation to a 100-mL volumetric flask, dilute with Mobile phase to volume, and mix.
System suitability preparation
Prepare a solution of 4¢-fluoroacetophenone in methanol containing about 1 mg per mL. Transfer 5.0 mL of this solution and 5.0 mL of Standard stock preparation to a 100-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Assay preparation
Transfer an accurately measured volume of Injection, equivalent to about 5 mg of droperidol, to a 100-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography
Procedure
Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of droperidol (C22H22FN3O2) in each mL of the Injection taken by the formula:
100(C / V)(rU / rS)
in which C is the concentration, in mg per mL, of USP Droperidol RS in the Standard preparation; V is the volume, in mL, of Injection taken; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
Chromatographic Column
USP32NF27 Page 2219
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.
|